Kopran Ltd.
NSE: KOPRAN | BSE: 524280
₹276.44
₹-6.54
(-2.31%)
As on 22-Sep-2026IST
Market cap
₹1,337 Cr
Revenue (TTM)
₹700 Cr
P/E Ratio
53.5
P/B Ratio
2.5
Div. Yield
1.1 %
Quality Score
3/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹25 Cr
-
ROE
4.9 %
-
ROCE
6.6 %
-
Industry P/E
48.44
-
EV/EBITDA
23.4
-
Debt to Equity
0.3
-
Book Value
₹111
-
EPS
₹5.2
-
Face value
10
-
Shares outstanding
48,326,105
10 Years Aggregate
CFO
₹310.50 Cr
EBITDA
₹587.17 Cr
Net Profit
₹350.55 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Kopran
| 83.8 | 41.0 | 42.5 | 60.3 | 7.6 | 4.9 | 17.6 |
|
BSE Healthcare
| 19.1 | 2.3 | 8.1 | 14.3 | 22.5 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Kopran
| -29.3 | -15.7 | 59.9 | -53.4 | 133.2 | 344.6 | -19.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Kopran
|
276.4 | 1,337.4 | 700.2 | 25.0 | 6.0 | 4.8 | 53.5 | 2.5 |
| 3,213.7 | 26,305.6 | 1,461.8 | 387.4 | 34.5 | 25.2 | 68.1 | 15.2 | |
| 840.2 | 16,518.2 | 7,784.0 | 688.5 | 10.6 | 14 | 23.8 | 2.8 | |
| 452.8 | 17,308.7 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.9 | 4.5 | |
| 864.1 | 23,581.8 | 5,632.3 | 662.4 | 17.2 | 14.3 | 35.6 | 4.8 | |
| 1,070.9 | 17,055.8 | 8,608.3 | 351.6 | 8.7 | 5.7 | 48.4 | 2.4 | |
| 1,587.9 | 18,203.8 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.1 | |
| 210.1 | 27,978.3 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.5 | |
| 1,671.2 | 27,675.3 | 1,935.8 | 288.2 | 20.6 | 29.8 | 96 | 20.6 | |
| 2,185.4 | 35,503.7 | 3,564.0 | 414.0 | 15.3 | 8.4 | 86.8 | 7.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Kopran
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage... forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gastrointestinal, erectile dysfunction, anthemintic, anti-allergic, central nervous system, anti-malarial, anti-thyroid, and carbapenems. In addition, the company offers drugs for anti-hypertensive, neuromodulator, anti-acne, anti-infective, antibiotic, anti-thrombotic, anti-diabetic, anti-asthamatic, antihyperlipidemic, anti-convulsants, anti-anxiety, pulmonary arterial hypertension, chronic heart failure, neuropathic pain, and erosive esophagitis. Kopran Limited was incorporated in 1958 and is based in Mumbai, India. Read more
-
Incorporated
1958
-
Chairman
Surendra Somani
-
Managing Director
Surendra Somani
-
Group
Parijat
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Kopran
What is the current share price of Kopran Ltd Today?
The share price of Kopran Ltd is ₹276.44 (NSE) and ₹276.75 (BSE) as of 22-Sep-2026 IST. Kopran Ltd has given a return of 7.56% in the last 3 years.
What is the current PB & PE ratio of Kopran Ltd?
The P/E ratio of Kopran Ltd is 53.53 times as on 22-Sep-2026, a 11 premium to its peers’ median range of 48.44 times.
The P/B ratio of Kopran Ltd is 2.49 times as on 22-Sep-2026, a 48 discount to its peers’ median range of 4.81 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
20.25 |
0.99 |
2025 |
21.93 |
1.64 |
2024 |
24.45 |
2.54 |
2023 |
19.55 |
1.21 |
2022 |
22.24 |
3.19 |
What is the 52 Week High and Low of Kopran Ltd?
The 52-week high and low of Kopran Ltd are Rs 286.53 and Rs 107.00 as of 23-Sep-2026.
What is the market cap of Kopran Ltd?
Kopran Ltd has a market capitalisation of ₹ 1,337 Cr as on 22-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Kopran Ltd?
Before investing in Kopran Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.